Works matching IS 03407004 AND DT 2020 AND VI 69 AND IP 10


Results: 21
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2041, doi. 10.1007/s00262-020-02608-6
    By:
    • Jikuya, Ryosuke;
    • Kishida, Takeshi;
    • Sakaguchi, Masahiko;
    • Yokose, Tomoyuki;
    • Yasui, Masato;
    • Hashizume, Akihito;
    • Tatenuma, Tomoyuki;
    • Mizuno, Nobuhiko;
    • Muraoka, Kentaro;
    • Umemoto, Susumu;
    • Kawai, Masaki;
    • Yoshihara, Mitsuyo;
    • Nakamura, Yoshiyasu;
    • Miyagi, Yohei;
    • Sasada, Tetsuro
    Publication type:
    Article
    10
    11
    12
    13

    Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy.

    Published in:
    Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2125, doi. 10.1007/s00262-020-02610-y
    By:
    • Vitale, Laura A.;
    • He, Li-Zhen;
    • Thomas, Lawrence J.;
    • Wasiuk, Anna;
    • O'Neill, Thomas;
    • Widger, Jenifer;
    • Crocker, Andrea;
    • Mills-Chen, Laura;
    • Forsberg, Eric;
    • Weidlick, Jeffrey;
    • Patterson, Colleen;
    • Hammond, Russell A.;
    • Boyer, James;
    • Sisson, Crystal;
    • Alvarado, Diego;
    • Goldstein, Joel;
    • Marsh, Henry C.;
    • Keler, Tibor
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21